These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10856565)

  • 21. Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction.
    Cantarovich M; Quantz M; Elstein E; Ergina P; Magnan C; de Varennes B
    Transplant Proc; 2000 Mar; 32(2):446-8. PubMed ID: 10715475
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation.
    Walker RE; McCrindle BW; Coles JG; West LJ
    Transplant Proc; 1998 Jun; 30(4):1116-7. PubMed ID: 9636452
    [No Abstract]   [Full Text] [Related]  

  • 23. Ten year experience in orthotopic heart transplantation: single center result.
    Aziz T; el-Gamel A; Krysiak P; Rahman A; Campbell C; Yonan N; Deiraniya A
    Transplant Proc; 1998 Aug; 30(5):1915-6. PubMed ID: 9723331
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclosporine-based steroid-free therapy in pediatric heart transplantation: long-term results.
    Livi U; Caforio AL; Gambino A; Tursi V; Milanesi O; Stellin G; Angelini A; Casarotto D
    Transplant Proc; 1998 Aug; 30(5):1975-6. PubMed ID: 9723358
    [No Abstract]   [Full Text] [Related]  

  • 25. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD; Flemming C
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of cyclosporine monitoring with trough levels to levels obtained 6 hours after the morning dose in heart transplant patients: a prospective randomized study.
    Cantarovich M; Latter D; Fitchett D
    Transplant Proc; 1997; 29(1-2):602-4. PubMed ID: 9123149
    [No Abstract]   [Full Text] [Related]  

  • 27. How many endomyocardial biopsies are necessary in the first year after heart transplantation?
    Sisson S; Jazzar A; Mischke L; Cooper DK; Zuhdi N
    Transpl Int; 1996; 9(3):243-7. PubMed ID: 8723194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
    Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B
    Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496
    [No Abstract]   [Full Text] [Related]  

  • 29. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
    Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
    Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
    [No Abstract]   [Full Text] [Related]  

  • 30. Increasing incidence of steroid resistant rejection in kidney transplantation.
    Arrazola L; Sozen H; Humar A; Papalois V; Uknis M; Matas AJ
    Transplant Proc; 2000 Nov; 32(7):1767. PubMed ID: 11119926
    [No Abstract]   [Full Text] [Related]  

  • 31. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation.
    Freise CE; Hebert M; Osorio RW; Nikolai B; Lake JR; Kauffman RS; Ascher NL; Roberts JP
    Transplant Proc; 1993 Apr; 25(2):1758-9. PubMed ID: 8470155
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K; Munn SR; Sterioff S
    Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract]   [Full Text] [Related]  

  • 33. Relevance of positive lymphocytotoxic crossmatch and immunosuppressive regimens in the outcome of liver transplants.
    Charco R; Vargas V; Balsells J; Lázaro JL; Murio E; Jaurrieta E; Martorell J; Margarit C
    Transplant Proc; 1997; 29(1-2):461-2. PubMed ID: 9123082
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience.
    Adamson R; Obispo E; Dychter S; Dembitsky W; Moreno-Cabral R; Jaski B; Gordon J; Hoagland P; Moore K; King J; Andrews J; Rich M; Daily PO
    Transplant Proc; 1998 Jun; 30(4):1107-9. PubMed ID: 9636449
    [No Abstract]   [Full Text] [Related]  

  • 35. Triple versus quadruple induction immunosuppression in pancreas transplantation.
    Wadström J; Brekke B; Wramner L; Ekberg H; Tydén G
    Transplant Proc; 1995 Feb; 27(1):1317-8. PubMed ID: 7878896
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction.
    Cantarovich M; de Gruchy S; Forbes C; Marpole D; Elstein E; Magnan C; de Varennes B
    Transplant Proc; 1999; 31(1-2):79. PubMed ID: 10083015
    [No Abstract]   [Full Text] [Related]  

  • 37. Low-dose oral prednisone in the treatment of acute cardiac allograft rejection.
    Delgado JF; Pombo M; Dalmau R; Gómez-Sánchez MA; Escribano P; Lázaro M; Velázquez MT; Sánchez V; Sáenz de la Calzada C; Rufilanchas JJ
    Transplant Proc; 2002 Feb; 34(1):117. PubMed ID: 11959215
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients.
    Walker S; Habib S; Thompson D; Khaghani A; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1149-51. PubMed ID: 9636465
    [No Abstract]   [Full Text] [Related]  

  • 40. Multicenter evaluation of immunosuppressive regimens in heart transplantation. The Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1997; 29(1-2):617-9. PubMed ID: 9123156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.